September 2, 2014

ORC reports on revision to Pari-Mutuel Tax Reduction Allocations

The Ontario Racing Commission (ORC) is pleased to announce the approval of the revised allocations of the Pari-Mutuel Tax Reduction (PMTR) to support and encourage the horse racing industry in Ontario. This is in keeping with the ORC’s mandate to implement the components of
the 5-year Horse Racing Partnership Plan (HRPP), as approved by the Ontario government.

As a result of the approval by the Board of the Ontario Horse Racing Industry Association (OHRIA) and the subsequent approval by the Board of the ORC, a new structure setting out the allocation of funds from the Pari-Mutuel Tax Reduction will be implemented with the effective date retroactive to April 1, 2014.

By way of this Notice to Industry, ORC licensed racetracks will be required to direct funds as prescribed below.

Horse Improvement Program 3.0 %

Horse People 0.4 %
Customer Benefits 1.5 %
Racetracks 1.25 %
Regulatory Funding 0.75 %
Total PMTR 6.9 %

The ORC will work with affected industry stakeholders to account for amounts paid since April 1, 2014 pursuant to the prior allocation to ensure compliance with these revised rates.

(ORC)

CPMA – Compounded Medication

The compounding of drugs is an accepted veterinary practice and when properly prescribed, created and administered, they can be an appropriate and effective treatment for your horse.  Click here to read the CPMA release in its entirety.

 

CPMA: Drug Appearing in Feed

The Canadian Pari-Mutuel Agency (CPMA) issued a memorandum to the horse racing industry late Friday warning of the drug ractopamine appearing in feedstuffs.

The English text from the memo appears below.

SUBJECT: Ractopamine in Feedstuffs

This memo is with respect to several recent positive drug tests that may have been the result of prohibited substances in feedstuffs. This is a reminder to owners and trainers that it remains their responsibility to obtain horse feed and supplements that are free from substances that may trigger a positive test.

One of these prohibited substances is ractopamine, which is used to promote weight gain and feed efficiency and is licenced in Canada for use in beef cattle, pigs and turkeys.

Following several positive tests in Ontario, the Ontario Racing Commission undertook an investigation that found ractopamine in batches of horse feed. Similar findings were heard from Alberta and Quebec. Upon receipt of this information, CPMA initiated discussions with the Canadian Food Inspection Agency (CFIA) wherein it was determined that the CFIA has set allowable limits of ractopamine to be present in feed. However, even if horse feed passes these allowable limit tests, the feed may contain enough ractopamine to cause a positive result in the CPMA’s drug testing program.

CFlA also advised that it has a program for feed mills that minimizes the likelihood of ractopamine being found in feed for animals destined for international markets that do not allow any amounts of ractopamine in exported meat. The threat of an unintended positive test result to Canadian horsepeople may be minimized in several ways including but not limited to obtaining feed from manufacturers certifying that ractopamine is not used in feed produced at their facility.

It is suggested that owner and trainers make agreements with feed suppliers that their feed come from sources that minimize the risks of contamination. As mentioned at the outset of this memo, positive tests remain the owner’s/trainer’s responsibility.

Medicating ingredients permitted in Canadian feeds that may cause a positive test in the CPMA’s drug testing program include but are not necessarily limited to: ractopamine, zilpaterol, procaine penicillin and levamisole.

The following links to the CFlA website provide owners and trainers with information regarding ractopamine and feed stuffs.

http://www.inspection.gc.ca/food/meat-and-poultry-products/manual-of-pro…

http://www.inspection.gc.ca/food/meat-and-poultry-products/manual-of-pro…

http://www.inspection.gc.ca/animals/feeds/medicating-ingredients/mib/dru…

Should you have any questions with respect to the contents of the memorandum, please do not hesitate to contact Lydia Brooks, Manager, Research and Analysis (613-949-0745) or Lydia.Brooks@agr.gc.ca or Dr. Adam Chamber (905-648-3033) or Adam.Chambers@agr.gc.ca

Sincerely,
Steve Suttie
A/Executive Director | Directeur exécutif intérimaire
Canadian Pari-Mutuel Agency | Agence canadienne du pari mutuel

(Standardbred Canada)

Pilot Project – Collection of Official Blood and TCO2 Samples

Notice to the Industry – Pilot Project combining collection of Official blood and TCO2 Samples

 The Ontario Racing Commission (ORC) and the Canadian Pari-Mutuel Agency (CPMA) will launch a pilot project that will allow for the collection of Official (blood) samples at the same time as TCO2 samples. The pilot will take place at The Raceway at Western Fair District, commencing on November 15, 2013 and will run throughout the 2013/2014 racing season.

In this pilot project Official blood samples will be collected by the TCO2 Technician from selected horses in their paddock stall pre-race. The pilot has been designed to run in conjunction with the current CPMA drug control program consisting of post-race Official sample collections. This means that horses that are selected for pre-race Official sample collections may also be selected for post-race Official sample collection.  Click here for more information.

(ORC)

CPMA Changes Withdrawal Time On Anti-Inflammatory “Firocoxib”

The Canadian Pari-Mutuel Agency (CPMA) has altered its guidleines concerning withdrawal times forthe non-steroidal anti-inflammatory called “Firocoxib”.

To read the complete Memorandum from CPMA, please Click Here.

 

CPMA: Current Medication Withdrawal Deadlines Not Affected

The Canadian Pari-Mutuel Agency (CPMA)has  issued the following memorandum to the Provincial Regulatory Bodies on Wednesday regarding the Racing Commissioners International (RCI) Medication Rules.


December 19, 2012

MEMORANDUM TO: Provincial Regulatory Bodies

SUBJECT: Modification to Racing Commissioners International Medication Rules

Racing Commissioners International (RCI) has recently announced preliminary approval for changes affecting the requirements for “Controlled Therapeutic Medications”, as newly-defined in the RCI Model Rules.

These changes intend to promote the adoption of uniform guidelines regarding the use of certain medications.

CPMA is a member of RCI, and sits on the Model Rules Committee. The CPMA supports efforts to harmonize rules affecting drug control, and will ensure that the Canadian approach to controlling the use of medications on race horses is informed by this RCI initiative.

However, the changes being developed to the RCI Model Rules (as posted by Standardbred Canada) do not affect the current CPMA withdrawal guidelines for any of the drugs listed, which remain  unchanged.

Should you have any further comment or questions, please contact Dr. Adam Chambers (905) 648-3033 or Lydia Brooks at (613) 949-0745.

(Standardbred Canada)

CPMA Adds Phenylpropanolamine To Prohibited Drug List

The Canadian Pari-Mutuel Agency has issued a directive prohibiting the use of Phenylpropanolamine for race horses. The official notice is available here.

CPMA Now Testing For Ethanol–Notice from Ontario Racing Commission

 

On January 16, 2012, the Canadian Pari-Mutuel Agency (CPMA) announced that official samples will be tested for ethanol, effective February 13, 2012.

Ethanol, a central nervous system depressant, is widely available in many forms. The CPMA is advising industry participants to take care and to read the label of ingredients when choosing products that are administered to horses. The Ontario Racing Commission (ORC) has noted this very same advice in previous Notices to the Industry.

To view the complete Notice to the Industry from the Ontario Racing Commission, please use this link: Notice to the Industry – CPMA now testing for ethanol